TP53 and breast cancer: Panels have been widely available in Brazil within the past 7 years, but no study has yet assessed the prevalence and mutational spectrum of germline variants in BC susceptibility genes other than BRCA1/2 and TP53 in a large cohort of individuals with BC, who were referred for genetic evaluation.